High Throughput Screening Market by Technology (Bioinformatics, Lab on a Chip, Cell-Based Assays) Application (Toxicology, Primary Screening, Target Identification & validation), End User (Academic and Government Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Others) and Region - Analysis & Forecast 2019-2030
Report ID : 22 | Published Date : Feb 2019 | Pages : 150 | Region : Global | Report Code : MD-12
High Throughput Screening Market Overview and Introduction
High Throughput Screening Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030. The global high throughput screening market was valued at over US$ 14.0 Mn in 2017 and is expected to grow at a substantial CAGR during the forecasted period.
High Throughput Screening is a scientific technique of experimentation which finds its use in the process of drug discovery. In this technique multiple experimental samples are simultaneously subjected to testing in a given laboratory condition. These tests range from genetic, pharmacological, chemical testing to several other forms of assays. The applications of such techniques are widely utilized in in rapid identification of antibodies, active compounds, and genes which influence distinctive biomolecular pathways among others.
Advent of new innovative technologies, increasing incidences of chronic disorders coupled with increasing investments in the sector of R&D has been a major factor contributing to the growth of this market. Moreover, wide scale adoption of advanced models to identify and screen drug targets is anticipated to present a lucrative scenario for the extensive growth of the high throughput screening market.
High Throughput Screening Market by Technology
The global high throughput screening market is segmented by technology, application, end user, and region. On the basis of technology, the high throughput screening market is segmented into bioinformatics, Lab-on-a-chip (LOC), cell-based assays, 2D cell culture, 3D cell culture, perfusion cell culture, ultra-high-throughput screening, and label-free technology. The segment of 3D Cell Culture can be further classified into scaffold-based technologies and scaffold-free technologies. Scaffold-based technologies segment is further classified into three major divisions’ micropatterned surfaces, inert matrix and hydrogels. Whereas, scaffold-free technologies segment can broadly be segmented into microplate, ultra-low binding plates, hanging-drop plates and other scaffold-free technologies. In terms of revenue, the segment of label-free technology is anticipated to account for the largest share of the global high throughput screening market. The growth of the segment can be attributed to the diverse application of label-free technologies in studying diverse types of cells, biological pathways and targets.
High Throughput Screening Market by Applications
The segment of applications is classified into toxicology assessment, primary & secondary screening, target identification & validation and others. The segment of target identification & validation is estimated to account for the largest share of the high throughput screening market, owing to the continual growth in the number of potential drug targets.
High Throughput Screening Market by End User
On the basis of end user the global high throughput screening market can be distinctly segmented into academic and government institutes, pharmaceutical and biotechnology companies, contract research organizations and others. Growing application of high throughput screening techniques for discovery of drugs and increasing investments in R&D is estimated to contribute significantly to the dominant market share of pharmaceutical and biotechnology companies segment.
High Throughput Screening Market by Regions
The global high throughput screening market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market of high throughput screening, followed by Europe and Asia Pacific. North America will continue to dominate the global high throughput screening market in the forecast period owing to factors such as highly developed healthcare system and presence of private and public funding. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered at China, India, and Japan. Factors such as the rising focus of major players in emerging Asian countries and government support are driving the growth of the high throughput screening market in this region.
High Throughput Screening Market Prominent Players
The prominent players in the global high throughput screening market are Agilent Technologies, Thermo Fisher Scientific, Danaher Corporation, Corning Incorporated, Aurora Instruments Ltd., BioTek Instruments, Inc., PerkinElmer Inc., Merck KGaA, AXXAM S.p.A., and Tecan Trading AG.